AUA Summit - Prostate Cancer

advertisement

Prostate Cancer

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme.

037IC – Using Shared Decision Making to Help Patients Decide on Prostate Cancer Screening and Treatment

Claim CME   Play   

037IC - Using Shared Decision Making to Help Patients Decide on Prostate Cancer Screening and Treatment

048IC – Novel Agents and Concepts in the Management of Hormone Naïve and Castrate Resistant Prostate Cancer

Claim CME   Play   

048IC - Novel Agents and Concepts in the Management of Hormone Naïve and Castrate Resistant Prostate Cancer

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genentech, Genomic Health, Merck, Pfizer, Inc. and Sanofi Genzyme.

077IC – Integrating Care for Oncology Patients: Establishing a Multidisciplinary Oncology Clinic with Advanced Therapeutics

Claim CME   Play   

077IC - Integrating Care for Oncology Patients: Establishing a Multidisciplinary Oncology Clinic with Advanced Therapeutics

013IC – Genetic Testing in Prostate Cancer: Understanding Clinical Implications for Early Detection, Localized Disease & CRPC

Claim CME   Play   

013IC - Genetic Testing in Prostate Cancer: Understanding Clinical Implications for Early Detection, Localized Disease & CRPC

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genentech, Genomic Health, Merck, Pfizer, Inc. and Sanofi Genzyme.

023IC – Chemotherapy and Immunotherapy Options for Genitourinary Malignancies: A Primer for Urologists and Advanced Practice Providers

Claim CME   Play   

023IC - Chemotherapy and Immunotherapy Options for Genitourinary Malignancies: A Primer for Urologists and Advanced Practice Providers

027IC – AUA Castration Resistant Prostate Cancer (CRPC) Guidelines and Therapeutic Advances in Metastatic Prostate Cancer

Claim CME   Play   

027IC - AUA Castration Resistant Prostate Cancer (CRPC) Guidelines and Therapeutic Advances in Metastatic Prostate Cancer

Satellite Symposia

Expert Insights on New Systemic Therapies for Advanced Prostate Cancer

CME   Play   

Expert Insights on New Systemic Therapies for Advanced Prostate Cancer